SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 7.11% in the revenue at Rs. 13043.70 millions was reported in the June 2022 quarter as compared to Rs. 12178.30 millions during year-ago period.Modest increase of 5.05% in the Net Profit was reported from. 1957.60 millions to Rs. 2056.40  millions.Operating Profit saw a handsome growth to 2967.60 millions from 2843.60 millions in the quarter ended June 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 13043.70 12178.30 7.11 13043.70 12178.30 7.11 49192.70 43100.20 14.14
Other Income 263.60 192.10 37.22 263.60 192.10 37.22 772.10 809.00 -4.56
PBIDT 2967.60 2843.60 4.36 2967.60 2843.60 4.36 11649.30 10023.60 16.22
Interest 42.20 50.40 -16.27 42.20 50.40 -16.27 191.00 182.80 4.49
PBDT 2925.40 2793.20 4.73 2925.40 2793.20 4.73 11458.30 9840.80 16.44
Depreciation 173.50 157.30 10.30 173.50 157.30 10.30 661.00 581.30 13.71
PBT 2751.90 2635.90 4.40 2751.90 2635.90 4.40 10797.30 9259.50 16.61
TAX 695.50 678.30 2.54 695.50 678.30 2.54 2810.30 2352.60 19.46
Deferred Tax -12.20 -27.80 -56.12 -12.20 -27.80 -56.12 41.80 -37.90 -210.29
PAT 2056.40 1957.60 5.05 2056.40 1957.60 5.05 7987.00 6906.90 15.64
Equity 212.50 212.50 0.00 212.50 212.50 0.00 212.50 212.50 0.00
PBIDTM(%) 22.75 23.35 -2.56 22.75 23.35 -2.56 23.68 23.26 1.82

Abbott India Share Price

25797.15 -65.00 (-0.25%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×